• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE Back to Search Results
Model Number 8637-40
Device Problems Failure to Interrogate (1332); Unstable (1667)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/29/2016
Event Type  Injury  
Manufacturer Narrative
References the main component of the device system; the other relevant components include:product id 8835, serial# (b)(4), product type programmer, patient.
 
Event Description
Information was received from a healthcare provider (hcp) via a clinical study regarding a patient who was receiving dilaudid (hydromorphone) and bupivacaine at unknown concentrations and doses for malignant pain and cancer pain.The patient reported they were experiencing difficulty when activating their personal therapy manager (ptm).They reportedthat the pump and ptm do not connect.An examination was performed on (b)(6) 2016, revealing that the pump was inverted, which could be the source of the difficulty.The device diagnosis was pump inversion.The pump was repositioned on (b)(6) 2017.The pump site was moved from low ¿rlq¿ to upper ¿rlq.¿ the event was related to the device/therapy.The event was not related to the implant procedure.The event resolved without sequelae on (b)(6) 2017.There were no reported symptoms.
 
Event Description
Additional information received from a healthcare provider (hcp) via a clinical study indicated the outcome was resolved without sequelae on (b)(6) 2017.The pump was delivering dilaudid (1.0 mg/ml at 0.1999 mg/day) and bupivacaine (30.0 mg/ml at 5.996 mg/day).
 
Event Description
Additional information received from a healthcare provider via a clinical study reported examination revealed that the pump had become dislodged from its sutures and was flipping with the pocket.It was noted the patient's baseline weight was (b)(6).
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNCHROMED II
Type of Device
PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer (Section G)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer Contact
lisa woodward clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key6311722
MDR Text Key66816212
Report Number3004209178-2017-02814
Device Sequence Number1
Product Code LKK
UDI-Device Identifier00643169508156
UDI-Public00643169508156
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,study
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 05/26/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/08/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/28/2017
Device Model Number8637-40
Device Catalogue Number8637-40
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/25/2017
Date Device Manufactured05/04/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age41 YR
Patient Weight113
-
-